Australia markets open in 5 hours 40 minutes

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3600+0.0003 (+0.08%)
At close: 04:00PM EST
0.3636 +0.00 (+1.00%)
After hours: 07:25PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 20.99M
Enterprise value 11.40M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.53
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.49

Trading information

Stock price history

Beta (5Y monthly) 1.20
52-week change 3-68.70%
S&P500 52-week change 314.90%
52-week high 31.3300
52-week low 30.2060
50-day moving average 30.3081
200-day moving average 30.4810

Share statistics

Avg vol (3-month) 3152.01k
Avg vol (10-day) 3320.31k
Shares outstanding 559.13M
Implied shares outstanding 659.13M
Float 849.11M
% held by insiders 111.01%
% held by institutions 118.18%
Shares short (14 Nov 2023) 433.05k
Short ratio (14 Nov 2023) 40.24
Short % of float (14 Nov 2023) 40.06%
Short % of shares outstanding (14 Nov 2023) 40.06%
Shares short (prior month 12 Oct 2023) 430.11k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 0.00%
Operating margin (ttm)-1,883.00%

Management effectiveness

Return on assets (ttm)-85.11%
Return on equity (ttm)-150.43%

Income statement

Revenue (ttm)932.32k
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)168.00%
Gross profit (ttm)N/A
EBITDA -23.41M
Net income avi to common (ttm)-23.85M
Diluted EPS (ttm)-0.5100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.73M
Total cash per share (mrq)0.16
Total debt (mrq)134.96k
Total debt/equity (mrq)0.99%
Current ratio (mrq)9.54
Book value per share (mrq)0.23

Cash flow statement

Operating cash flow (ttm)-19.53M
Levered free cash flow (ttm)-9.64M